To explore the relationship between genetic factors, lifestyle, and drug interventions and the occurrence, development, adverse pregnancy outcomes, and postpartum maternal-infant outcomes of gestational endocrine diseases.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Composite adverse maternal and neonatal outcomes associated with gestational endocrine disorders
Timeframe: From delivery (Day 0) through the initial birth hospitalization, assessed up to 14 days postpartum.
Postpartum glucose metabolism outcomes in patients with endocrine disorders in pregnancy
Timeframe: From 6 weeks postpartum through long-term follow-up, with assessments at 6 weeks and every 12 months thereafter, for ≥3 years and up to 40 years postpartum.
Postpartum thyroid disease outcomes in patients with endocrine disorders in pregnancy
Timeframe: From 6 weeks postpartum through long-term follow-up, with assessments at 6 weeks and every 12 months thereafter, for ≥3 years and up to 40 years postpartum.